Rocket Pharmaceuticals, Cranbury, NJ

Rocket Pharmaceuticals

www.rocketpharma.com

Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company advancing numerous gene therapies that could cure rare childhood diseases. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for seeking gene therapy cures for devastating diseases and making a difference for patients. Become an integral part of a small, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. ...

More>>

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.rocketpharma.com
9 Cedarbrook Drive
Cranbury, NJ USA 08512
Phone: 646.440.9100

Name	Title	Contact Details
Kinnari Patel	President, Head of Research & Development and Chief Operating Officer	Profile
Chris Stevens	Chief Operating Officer	Profile
Chantal Petit	VP, Chief of Staff supporting the President/Head R&D/COO at Rocket Pharmaceuticals	Profile
Mayo Pujols	Executive Vice President and Chief Technical Officer	Profile

Similar Companies

Zevra Therapeutics

We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients lives.

CTOs on the Move